Please login to the form below

Not currently logged in
Email:
Password:

antibodies

This page shows the latest antibodies news and features for those working in and with pharma, biotech and healthcare.

A look ahead to key trial readouts at ESMO

A look ahead to key trial readouts at ESMO

RG7461, a targeted immunocytokine combining an engineered interleukin-2 variant with an antibody against fibroblast activation protein (FAP).

Latest news

More from news
Approximately 19 fully matching, plus 937 partially matching documents found.

Latest Intelligence

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene’s drug is potentially differentiated from other PD-1s because of the antibody’s engineered Fc region, which preclinical data suggests could minimise potentially negative interactions with other immune cells.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Following after the first generation of mainly antibody-based

  • 30 Women Leaders in UK Healthcare

    She works mainly in the translational field, focusing on the design and construction of antibody-based therapeutics to hit specific cancer targets. ... Current projects include developing antibodies for use as cancer imaging agents, antibody drug

  • Leo has its eyes on the prize Leo has its eyes on the prize

    Its landmark partnership with AstraZeneca and the launch of Kyntheum, the fully-human monoclonal antibody targeting psoriasis, and the phase III hope of tralokinumab for atopic dermatitis are part of an

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... licence agreement in January with respect to calcitonin gene-related peptide

More from intelligence
Approximately 1 fully matching, plus 96 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics